Endpoint definition
↥Filter registries Inpat., Oupat., Death
Check pre-conditions None
Include endpoints None
Check conditions None
Apply sex-specific rule None
Extra metadata
muscular disease: Acquired, familial, and congenital disorders of skeletal muscle and smooth muscle.
Filter registries Inpat., Oupat., Death
Check pre-conditions None
Include endpoints None
Check conditions None
Apply sex-specific rule None
Extra metadata
List of similar endpoints to
Hypertrophy of (infrapatellar) fat pad
based on the number of shared cases.
Broader endpoints:
Narrower endpoints:
None
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 180 | 110 | 70 |
| Unadjusted prevalence (%) | 0.07 | 0.07 | 0.06 |
| Mean age at first event (years) | 38.70 | 38.31 | 39.32 |
| Follow-up | Absolute risk | HR [95% CI] | p | N |
|---|---|---|---|---|
| 1998–2019 | - | - | - | - |
| 15 years | - | - | - | - |
| 5 years | - | - | - | - |
| 1 year | - | - | - | - |
Index endpoint: M13_FATPADHYPERTROPHY – Hypertrophy of (infrapatellar) fat pad
GWS hits: 0
before Hypertrophy of (infrapatellar) fat pad
after Hypertrophy of (infrapatellar) fat pad
Loading survival analyses plot
Loading survival analyses table